An HIV Vaccine in the Era of Twice-Yearly Lenacapavir for PrEP — Essential or Irrelevant?

作者：Lauren P. Jatt, Nyaradzo Mgodi, Susan P. Buchbinder, Glenda Gray, James G. Kublin · 发表于：New England Journal of Medicine · 年份：2025 · DOI：10.1056/nejmp2415893 · 被引用次数：8 · 研究领域：HIV-related health complications and treatments、HIV/AIDS Research and Interventions、HIV Research and Treatment

The discovery of a highly efficacious option for preexposure prophylaxis that requires only twice-yearly administration has led to the question of whether a vaccine is still needed to end the HIV epidemic.